비교리스트

 카트 문의
시장보고서
상품코드
1565149

세계의 신경보철 시장

Neuroprosthetics
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 193 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

신경보철 세계 시장은 2030년까지 252억 달러에 달할 것으로 전망

2023년 114억 달러로 추정되는 신경 보철 세계 시장은 2023-2030년의 분석 기간 동안 연평균 12.0% 성장하여 2030년에는 252억 달러에 달할 것으로 예상됩니다. 본 보고서에서 분석한 부문 중 하나인 운동 신경 장애 분야는 CAGR 13.5%를 기록하여 분석 기간 종료 시점에 158억 달러에 도달할 것으로 예상됩니다. 인지 장애 분야의 성장률은 분석 기간 동안 CAGR 10.9%로 추정됩니다.

미국 시장은 30억 달러로 추정, 중국은 CAGR 10.9%로 성장 전망

미국의 신경보철 시장은 2023년 30억 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2030년까지 38억 달러 규모에 도달할 것으로 예상되며, 2023-2030년의 분석 기간 동안 10.9%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 11.1%와 9.9%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 유럽에서는 독일이 연평균 8.2%의 성장률을 보일 것으로 예상됩니다.

세계 신경보철 시장 - 주요 동향 및 촉진요인 요약

신경보철이란 무엇이며 왜 변화를 가져오는가?

신경보철은 신경계와 인터페이스하여 부상, 질병, 선천성 질환으로 인해 상실된 신경 기능을 회복하거나 강화하는 첨단 의료기기입니다. 이러한 장치는 신경계의 특정 부위에 전기 신호를 보내 운동 조절, 감각 지각, 인지 기능 등의 기능을 대체하거나 보조할 수 있습니다. 신경보철의 대표적인 예로는 청력 회복을 위한 인공와우, 파킨슨병을 위한 뇌심부자극(DBS) 장치, 마비 환자가 로봇 팔다리를 조작할 수 있도록 하는 뇌-기계 인터페이스 등이 있습니다.

신경보철의 혁신적인 특성은 중증 장애를 가진 사람들의 독립성을 회복하고 삶의 질을 향상시키는 능력에 있습니다. 이러한 장치는 간질, 뇌졸중, 척수 손상 등 다양한 신경 질환을 치료할 수 있는 새로운 가능성을 제시했습니다. 신경 보철 기술이 발전함에 따라 실시간으로 뇌와 상호작용할 수 있는 보다 정교한 시스템을 개발할 수 있는 가능성이 현실화되고 있으며, 이는 전 세계 수백만 명의 환자들에게 새로운 희망을 가져다주고 있습니다.

신경보철 시장은 어떻게 진화하고 있는가?

신경보철 시장은 재료과학, 신경과학, 생물공학의 발전으로 빠르게 진화하고 있습니다. 이 시장에서 가장 중요한 트렌드 중 하나는 외부 전선이나 부피가 큰 하드웨어가 필요 없는 무선 신경 보철 시스템의 개발입니다. 이러한 무선 장치는 환자에게 더 큰 이동성과 편안함을 제공하는 동시에 유선 시스템과 관련된 감염 위험을 줄여줍니다. 또한, 신경 보철 부품의 소형화는 신체와의 원활한 통합을 가능하게 하여 기기의 기능성과 심미성을 모두 향상시킵니다.

또 다른 중요한 추세는 신경 보철에서 머신러닝과 AI의 사용이 증가하고 있으며, AI 알고리즘을 통합함으로써 이러한 기기는 환자의 신경 패턴에서 학습하고 특정 요구에 적응하여보다 개인화되고 효과적인 치료를 제공할 수 있습니다. 이는 로봇 팔다리와 같은 외부 기기를 제어하기 위해 뇌 신호의 실시간 분석에 의존하는 뇌-컴퓨터 인터페이스(BCI)에 특히 중요하며, AI 기술이 발전함에 따라 신경 보철은 더욱 직관적이고 반응성이 높아져 환자의 삶에 더 큰 영향을 미칠 것으로 예상됩니다. 더욱 향상될 것으로 예상됩니다.

신경보철의 보급을 촉진하는 질환은?

신경 보철의 채택을 촉진하는 몇 가지 신경 질환은 난청, 파킨슨병, 마비 등 신경 보철의 채택을 촉진하고 있습니다. 가장 널리 사용되는 신경 보철물인 인공와우는 수백만 명의 중증 난청 환자들이 청력을 되찾는 데 도움을 주고 있습니다. 이 장치는 귀의 손상된 부분을 우회하여 청각 신경을 직접 자극하여 소리 신호가 뇌에 도달 할 수있는 명확한 경로를 제공합니다.

파킨슨병 치료에서 뇌심부자극(DBS) 장치는 떨림과 경직과 같은 운동 증상을 조절할 수 있는 수단을 제공함으로써 환자 치료에 혁명을 일으켰으며, DBS 장치는 뇌의 특정 부위에 전기 자극을 보내 비정상적인 신경 활동을 제어합니다. 마찬가지로, 척수 손상이나 마비를 위한 신경 보조 장치도 널리 보급되고 있습니다. 이러한 장치는 종종 뇌-컴퓨터 인터페이스와 결합되어 마비 환자가 자신의 생각을 사용하여 로봇 팔다리와 외골격을 조작하여 이전에는 불가능했던 수준의 이동성을 회복 할 수 있습니다.

신경보철 시장의 주요 성장 촉진요인은?

신경보철 시장의 성장은 여러 가지 요인에 의해 이루어집니다. 주요 요인 중 하나는 난청, 간질, 파킨슨병, 척수 손상과 같은 신경 질환의 유병률 증가입니다. 세계 인구의 고령화에 따라 이러한 질환의 유병률이 증가하면서 신경 보철 솔루션에 대한 수요가 증가할 것으로 예상됩니다. 또한, 재료, AI, 생체공학의 기술 발전이 빠르게 진행되어 신경보철이 더욱 효과적이고 편안해져 더 많은 환자들이 이용할 수 있게 된 것도 큰 원동력이 되고 있습니다.

개인맞춤형 의료에 대한 관심이 높아짐에 따라 신경보조기구가 환자 개개인의 특정 요구에 맞게 조정될 수 있도록 하는 시장도 성장하고 있습니다. 또한, 신경학 연구개발에 대한 투자 증가와 의료기기에 대한 양호한 규제 환경은 기술 혁신과 시장 확대의 기회를 창출하고 있습니다. 신경 보철 연구, 특히 뇌-컴퓨터 인터페이스에 대한 공공 및 민간 자금 증가는 이 시장의 성장을 더욱 가속화하고 있습니다.

조사 대상 기업 예시(주목받는 44개사)

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • LivaNova PLC
  • Medtronic PLC
  • NDI Medical
  • NeuroPace, Inc.
  • Nevro Corp.
  • Retina Implant AG
  • Second Sight Medical Products, Inc.
  • Sonova Holding AG

    목차

    제1장 조사 방법

    제2장 주요 요약

    • 시장 개요
    • 주요 기업
    • 시장 동향과 촉진요인
    • 세계 시장 전망

    제3장 시장 분석

    • 미국
    • 캐나다
    • 일본
    • 중국
    • 유럽
    • 프랑스
    • 독일
    • 이탈리아
    • 영국
    • 기타 유럽
    • 아시아태평양
    • 기타 지역

    제4장 경쟁

    LSH 24.10.08

    Global Neuroprosthetics Market to Reach US$25.2 Billion by 2030

    The global market for Neuroprosthetics estimated at US$11.4 Billion in the year 2023, is expected to reach US$25.2 Billion by 2030, growing at a CAGR of 12.0% over the analysis period 2023-2030. Motor Neuron Disorders Application, one of the segments analyzed in the report, is expected to record a 13.5% CAGR and reach US$15.8 Billion by the end of the analysis period. Growth in the Cognitive Disorders Application segment is estimated at 10.9% CAGR over the analysis period.

    The U.S. Market is Estimated at US$3.0 Billion While China is Forecast to Grow at 10.9% CAGR

    The Neuroprosthetics market in the U.S. is estimated at US$3.0 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.8 Billion by the year 2030 trailing a CAGR of 10.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.1% and 9.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.2% CAGR.

    Global Neuroprosthetics Market - Key Trends & Drivers Summarized

    What Are Neuroprosthetics and Why Are They Transformative?

    Neuroprosthetics are advanced medical devices that interface with the nervous system to restore or enhance neurological functions that have been lost due to injury, disease, or congenital conditions. These devices can replace or assist functions such as motor control, sensory perception, and even cognitive functions by sending electrical signals to specific areas of the nervous system. Common examples of neuroprosthetics include cochlear implants for hearing restoration, deep brain stimulation (DBS) devices for Parkinson’s disease, and brain-machine interfaces that enable paralyzed individuals to control robotic limbs.

    The transformative nature of neuroprosthetics lies in their ability to restore independence and improve the quality of life for individuals with severe disabilities. These devices have opened new possibilities in treating a wide range of neurological disorders, including epilepsy, stroke, and spinal cord injuries. As advancements in neuroprosthetic technology continue, the potential for developing more sophisticated systems that can interact with the brain in real-time is becoming a reality, offering new hope to millions of patients worldwide.

    How Is the Neuroprosthetics Market Evolving?

    The neuroprosthetics market is evolving rapidly, driven by advances in materials science, neuroscience, and bioengineering. One of the most significant trends in this market is the development of wireless neuroprosthetic systems that eliminate the need for external wires or bulky hardware. These wireless devices provide greater mobility and comfort for patients, while also reducing the risk of infection associated with wired systems. Additionally, the miniaturization of neuroprosthetic components has enabled more seamless integration with the body, improving both the functionality and aesthetic appeal of the devices.

    Another key trend is the increasing use of machine learning and AI in neuroprosthetics. By incorporating AI algorithms, these devices can learn from a patient's neural patterns and adapt to their specific needs, providing more personalized and effective treatment. This is particularly important for brain-computer interfaces (BCIs), which rely on real-time analysis of brain signals to control external devices such as robotic limbs. As AI technology continues to advance, neuroprosthetics are expected to become more intuitive and responsive, further enhancing their impact on patients’ lives.

    Which Conditions Are Driving Neuroprosthetic Adoption?

    Several neurological conditions are driving the adoption of neuroprosthetics, with the most prominent being hearing loss, Parkinson’s disease, and paralysis. Cochlear implants, the most widely used neuroprosthetic devices, have helped millions of individuals with severe hearing impairments regain the ability to hear. These devices work by bypassing damaged parts of the ear and directly stimulating the auditory nerve, providing a clear path for sound signals to reach the brain.

    In the treatment of Parkinson’s disease, deep brain stimulation (DBS) devices have revolutionized patient care by providing a means of controlling motor symptoms such as tremors and rigidity. DBS devices send electrical impulses to specific areas of the brain to regulate abnormal neural activity. Similarly, neuroprosthetic devices for spinal cord injuries and paralysis are gaining traction. These devices, often coupled with brain-computer interfaces, enable paralyzed patients to control robotic limbs or exoskeletons using their thoughts, restoring a level of mobility that was previously unattainable.

    What Are the Key Growth Drivers in the Neuroprosthetics Market?

    The growth in the neuroprosthetics market is driven by several factors. One of the primary drivers is the increasing prevalence of neurological disorders, including hearing loss, epilepsy, Parkinson’s disease, and spinal cord injuries. As the global population ages, the incidence of these conditions is expected to rise, driving demand for neuroprosthetic solutions. Another major driver is the rapid pace of technological advancements in materials, AI, and bioengineering, which are making neuroprosthetics more effective, comfortable, and accessible to a broader patient population.

    The expanding focus on personalized medicine is also pushing the market forward, as neuroprosthetic devices are increasingly being tailored to meet the specific needs of individual patients. Additionally, the growing investments in neurological research and development, along with favorable regulatory environments for medical devices, are creating opportunities for innovation and market expansion. The rise in public and private funding for neuroprosthetic research, particularly in brain-computer interfaces, is further accelerating the growth of this market.

    Select Competitors (Total 44 Featured) -

    • Abbott Laboratories
    • Boston Scientific Corporation
    • Cochlear Ltd.
    • LivaNova PLC
    • Medtronic PLC
    • NDI Medical
    • NeuroPace, Inc.
    • Nevro Corp.
    • Retina Implant AG
    • Second Sight Medical Products, Inc.
    • Sonova Holding AG

    TABLE OF CONTENTS

    I. METHODOLOGY

    II. EXECUTIVE SUMMARY

    • 1. MARKET OVERVIEW
      • Influencer Market Insights
      • World Market Trajectories
      • Global Economic Update
      • Neuroprosthetics - Global Key Competitors Percentage Market Share in 2024 (E)
      • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • 2. FOCUS ON SELECT PLAYERS
    • 3. MARKET TRENDS & DRIVERS
      • Growing Incidence of Neurological Disorders and Disabilities Drives Demand for Neuroprosthetic Devices
      • Advancements in Brain-Computer Interface (BCI) Technology Propel Growth in Neuroprosthetics for Motor Function Rehabilitation
      • Rising Adoption of Cochlear Implants and Auditory Neuroprosthetics Expands Market in Hearing Restoration Applications
      • Increasing Use of Neuroprosthetics for Deep Brain Stimulation (DBS) Strengthens Business Case for Parkinsons and Epilepsy Treatment
      • Growing Integration of AI and Machine Learning in Neuroprosthetics Fuels Innovation in Personalized Rehabilitation Therapies
      • Surge in Demand for Retinal Implants and Visual Neuroprosthetics Expands Opportunities in Vision Restoration Technologies
      • Technological Advancements in Wireless Neuroprosthetics Drive Growth in Wearable and Portable Devices for Neurological Patients
      • Increasing Use of Neuroprosthetics in Spinal Cord Injury Rehabilitation Spurs Demand for Advanced Neural Interface Devices
      • Emerging Focus on Peripheral Nerve Stimulation in Neuroprosthetics Expands Applications in Pain Management and Neuroplasticity
      • Rising Adoption of Neuroprosthetics in the Treatment of Epilepsy and Tremors Expands Market for Brain Stimulation Devices
      • Growing Interest in Neuroprosthetic Solutions for Stroke Recovery Drives Innovation in Brain-Machine Interfaces for Motor Function Restoration
    • 4. GLOBAL MARKET PERSPECTIVE
      • TABLE 1: World Neuroprosthetics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
      • TABLE 2: World Recent Past, Current & Future Analysis for Neuroprosthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
      • TABLE 3: World 7-Year Perspective for Neuroprosthetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
      • TABLE 4: World Recent Past, Current & Future Analysis for Motor Neuron Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
      • TABLE 5: World 7-Year Perspective for Motor Neuron Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
      • TABLE 6: World Recent Past, Current & Future Analysis for Cognitive Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
      • TABLE 7: World 7-Year Perspective for Cognitive Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
      • TABLE 8: World Recent Past, Current & Future Analysis for Physiological Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
      • TABLE 9: World 7-Year Perspective for Physiological Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
      • TABLE 10: World Recent Past, Current & Future Analysis for Spinal Cord Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
      • TABLE 11: World 7-Year Perspective for Spinal Cord Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
      • TABLE 12: World Recent Past, Current & Future Analysis for Deep Brain Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
      • TABLE 13: World 7-Year Perspective for Deep Brain Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
      • TABLE 14: World Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
      • TABLE 15: World 7-Year Perspective for Vagus Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
      • TABLE 16: World Recent Past, Current & Future Analysis for Sacral Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
      • TABLE 17: World 7-Year Perspective for Sacral Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
      • TABLE 18: World Recent Past, Current & Future Analysis for Transcranial Magnetic Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
      • TABLE 19: World 7-Year Perspective for Transcranial Magnetic Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

    III. MARKET ANALYSIS

    • UNITED STATES
      • Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
      • TABLE 20: USA Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 21: USA 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
      • TABLE 22: USA Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 23: USA 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
    • CANADA
      • TABLE 24: Canada Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 25: Canada 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
      • TABLE 26: Canada Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 27: Canada 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
    • JAPAN
      • Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
      • TABLE 28: Japan Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 29: Japan 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
      • TABLE 30: Japan Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 31: Japan 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
    • CHINA
      • Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
      • TABLE 32: China Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 33: China 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
      • TABLE 34: China Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 35: China 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
    • EUROPE
      • Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
      • TABLE 36: Europe Recent Past, Current & Future Analysis for Neuroprosthetics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
      • TABLE 37: Europe 7-Year Perspective for Neuroprosthetics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
      • TABLE 38: Europe Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 39: Europe 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
      • TABLE 40: Europe Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 41: Europe 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
    • FRANCE
      • Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
      • TABLE 42: France Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 43: France 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
      • TABLE 44: France Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 45: France 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
    • GERMANY
      • Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
      • TABLE 46: Germany Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 47: Germany 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
      • TABLE 48: Germany Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 49: Germany 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
    • ITALY
      • TABLE 50: Italy Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 51: Italy 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
      • TABLE 52: Italy Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 53: Italy 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
    • UNITED KINGDOM
      • Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
      • TABLE 54: UK Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 55: UK 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
      • TABLE 56: UK Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 57: UK 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
    • REST OF EUROPE
      • TABLE 58: Rest of Europe Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 59: Rest of Europe 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
      • TABLE 60: Rest of Europe Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 61: Rest of Europe 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
    • ASIA-PACIFIC
      • Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
      • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 63: Asia-Pacific 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
      • TABLE 64: Asia-Pacific Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 65: Asia-Pacific 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
    • REST OF WORLD
      • TABLE 66: Rest of World Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 67: Rest of World 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
      • TABLE 68: Rest of World Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 69: Rest of World 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030

    IV. COMPETITION

    • 비교리스트
    0 건의 상품을 선택 중
    상품 비교하기
    전체삭제